Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

6.75USD
21 Sep 2018
Change (% chg)

$-0.15 (-2.17%)
Prev Close
$6.90
Open
$6.96
Day's High
$7.00
Day's Low
$6.69
Volume
319,208
Avg. Vol
160,662
52-wk High
$29.02
52-wk Low
$6.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 19.38 -0.144
Mar '18 11.19 -0.402
FY 2017 Dec '17 12.99 -0.290
Sep '17 18.08 -0.127
Jun '17 20.29 -0.105
Mar '17 20.29 -0.017
FY 2016 Dec '16 20.29 0.076
Sep '16 16.91 0.004
Jun '16 0.00 -0.238
Mar '16 0.00 -6.811
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 13.12 15.50 11.00 74.10
Quarter Ending Dec-18 6 12.61 15.50 10.68 104.10
Year Ending Dec-18 6 56.46 61.57 53.00 119.14
Year Ending Dec-19 6 68.55 86.25 43.00 68.75
Earnings (per share)
Quarter Ending Sep-18 6 -0.34 -0.27 -0.42 1.58
Quarter Ending Dec-18 6 -0.37 -0.27 -0.48 2.50
Year Ending Dec-18 6 -1.26 -1.08 -1.44 -0.19
Year Ending Dec-19 6 -1.22 -0.25 -2.33 -2.62
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) 3.57 110.30 6.46
Price to Book (MRQ) 2.03 12.48 3.90
Price to Tangible Book (MRQ) 2.03 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -4.49 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -20.75 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -36.79 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -2,179.81 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 3.58 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 0.00 18.62 14.06
Interest Coverage (TTM) -- -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -51.28 -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -57.35 -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -52.27 -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -50.54 -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 550,348 5,335,375 714,979,821
Net Income/Employee (TTM) -278,125 -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.21 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -10.57 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -14.00 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -21.77 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % 92.61 -- --
EPS (TTM) % 20.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Jounce Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -18.77 -20.30 11 74
13 Week -20.68 -25.41 28 56
26 Week -71.91 -75.18 4 45
52 Week -54.30 -60.99 16 88
YTD -47.06 -51.69 16 80
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.74%
# of Holders: 118
Total Shares Held: 26,997,700
3 Mo. Net Change: -2,523,792
# New Positions: 21
# Closed Positions: 40
# Increased Positions: 64
# Reduced Positions: 65
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.